(Q44306671)

English

Mucosal priming with PEI/DNA complex and systemic boosting with recombinant TianTan vaccinia stimulate vigorous mucosal and systemic immune responses

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Mucosal priming with PEI/DNA complex and systemic boosting with recombinant TianTan vaccinia stimulate vigorous mucosal and systemic immune responses (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

systemic immune response

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

author name string

Xianggang Huang

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Jianqing Xu

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Li Ren

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Lianxing Liu

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Yanmin Wan

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Ning Zhang

7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Hong Peng

8

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Yiming Shao

9

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

language of work or name

0 references

publication date

28 December 2006

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

2620-2629

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Systemic immunity and mucosal immunity are induced against human immunodeficiency virus Gag protein in mice by a new hyperattenuated strain of Listeria monocytogenes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Effect of CD8+ lymphocyte depletion on virus containment after simian immunodeficiency virus SIVmac251 challenge of live attenuated SIVmac239delta3-vaccinated rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3zeta and CD28, key signaling molecules for T-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Low levels of perforin expression in CD8+ T lymphocyte granules in lymphoid tissue during acute human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL), virus load, and CD4 T cell loss: evidence supporting a protective role for CTL in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Host determinants in HIV infection and disease. Part 1: cellular and humoral immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

AIDS pathogenesis: a finite immune response to blame?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Poly(ethylenimine) and its role in gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Aerosol delivery of robust polyethyleneimine-DNA complexes for gene therapy and genetic immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Enhanced gene expression in mouse lung after PEI-DNA aerosol delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

PEI - a potent, but not harmless, mucosal immuno-stimulator of mixed T-helper cell response and FasL-mediated cell death in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Intranasal immunization with inactivated influenza virus enhances immune responses to coadministered simian-human immunodeficiency virus-like particle antigens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Vaccination strategies for mucosal immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Transmission of HIV-1 during primary infection: relationship to sexual risk and sexually transmitted infections.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Ontogeny and specificities of mucosal and blood human immunodeficiency virus type 1-specific CD8(+) cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

New strategies for using mucosal vaccination to achieve more effective immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Identifying vaccine antigens and assessing delivery systems for the prevention of bacterial infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Mucosal immunity: some historical perspective on host-pathogen interactions and implications for mucosal vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Suppression of the immune response by nasal immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Prime-boost immunization with DNA vaccine: mucosal route of administration changes the rules

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Cytokines as adjuvants for the induction of anti-human immunodeficiency virus peptide immunoglobulin G (IgG) and IgA antibodies in serum and mucosal secretions after nasal immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Immunogenicity of an HIV-1 gag DNA vaccine carried by attenuated Shigella

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Nuclear targeting peptide scaffolds for lipofection of nondividing mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Intravascular and endobronchial DNA delivery to murine lung tissue using a novel, nonviral vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Intracellular route and transcriptional competence of polyethylenimine-DNA complexes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Nanoscopic structure of DNA condensed for gene delivery.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Gene delivery to the lung using protein/polyethylenimine/plasmid complexes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Intranasal interleukin-12 gene therapy enhanced the activity of ifosfamide against osteosarcoma lung metastases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Rapid crossing of the pulmonary endothelial barrier by polyethylenimine/DNA complexes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Prolonged organ retention and safety of plasmid DNA administered in polyethylenimine complexes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Prime-boost vaccination with HIV-1 Gag protein and cytosine phosphate guanosine oligodeoxynucleotide, followed by adenovirus, induces sustained and robust humoral and cellular immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2006.12.020

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44306671&oldid=2109323906"